Final Assignment: Drug Discovery PHAR2010
The class is divided into groups of 2-5 students to prepare a portfolio equivalent of about 2000 words per student (app. 10 pages per group member, including figures, tables and reference; max. 60 pages in total) and a final ppt presentation of max. 15 minutes (max. 16 slides) to be given in class in the last week of SP5.
Each group has been given at least one paper describing the role of a potential drug target for the treatment of a disease. This information will be used as starting point to develop a plan for a drug discovery project.
Collect additional information from literature and the internet to address the following points in your portfolio:
•Describe the disease (e.g. Alzheimers) and the therapeutic area (e.g. neurodegenerative diseases) -current treatment options; adverse effects
-unmet medical needs
-market consideration; financial burden; number of patients
•Describe your target
-molecular mechanism and link to disease (animal models; genetic defects)
-protein structure of target
-target class; closely related targets with potential for specificity problems
-other potential targets
-novel, first in class, orphan disease, “me too”
-design assay for primary screening strategy
-compound selection (e.g. diverse library, focussed library, natural products, rational design etc.)
•Verification of primary hits
-design assay for follow-up (verification, dose response studies)
-design assays for specificity testing if necessary
-identify suitable animal models to reach early proof of concept (ePOC)
•Compound profiling for prediction of adverse effects
-ADME / Tox
•Address potential problems for development
Notes for Portfolio
-You must not address every single point of this list. It is up to you to decide which topics are of central interest for your target and which parts you can keep short. You also may add new themes which are specific for your project.
-Your final document must have a title page with all student names, table of contents, numbered pages and a list of correctly annotated references.
Notes for Final Presentation
-It is suggested that every opportunity be taken to observe others when they give oral presentations. Think critically about where they are standing, speaking speed, voice volume, eye contact, reading directly from slides.
-Make sure your presentation is not too long. Cut down some of the material presented if necessary.
-Slide formatting Font
•Sizes between 20 and 28 are preferred. If there is insufficient space for at least 20 font, then split any specific slide into two, then increase the font size for half the information on each.
•A non-serif font is easier to read (e.g. Arial, Calibri etc.), although a serif type font is probably better for large documents, portfolios or books (e.g. Times New Roman).
•Choose a good background to fit with writing, figures, schemes and diagrams.
There is no substitute for practice. Some may not have to practice as much as others. It is always clear when much practice has been done, or not done. Even the most nervous person can overcome nervousness with sufficient effort.
-SI units and SI formatting
SI units should be used almost all times. One obvious exception (the only exception?) in medicine is blood pressure, which continues to be expressed as millimetres of mercury (mm Hg). Note that there should be consistency for use of standard units. If abbreviations are to be used (much preferred) then they should be introduced at first use and from there on always be used for all units. For the portfolio it might be useful to include a table of abbreviations.
Try to stay clear of jargon or common expressions that are used in some informal speech. For example, avoid the use of “stuff like that”, “and stuff”, “gunna”.
Despite common usage, it is preferred to say “data are” rather than “data is” or “data were” rather than